Publication:
Mapping the peptide interaction fingerprint of the Behçet's disease-associated HLA-B(∗)51

dc.contributor.coauthorYilmaz, S. Z.
dc.contributor.coauthorBasturk, D.
dc.contributor.coauthorGul, A.
dc.contributor.coauthorGur, M.
dc.contributor.departmentDepartment of Chemical and Biological Engineering
dc.contributor.kuauthorErman, Burak
dc.contributor.schoolcollegeinstituteCollege of Engineering
dc.date.accessioned2026-07-07T08:49:59Z
dc.date.issued2026
dc.description.abstractThe strongest genetic risk factor for Behçet’s disease, a relapsing inflammatory disorder marked by recurrent mucocutaneous ulcers and uveitis, is HLA-B∗51:01, a class I major histocompatibility complex (MHC class I) allele that presents intracellular peptides to CD8+ T cells. The molecular mechanisms linking the peptide preferences of this allele to dysregulated immunity remain unclear, limiting efforts to design peptide-based modulators of antigen presentation. Here, we define HLA-B∗51:01’s peptide selection rules by mapping the “interaction fingerprint” of 36 self-peptides using an extensive set of all-atom molecular dynamics simulations. These uncovered a conserved hydrophobic-polar blueprint tuned by peptide length. In silico pulling experiments performed at high-speed atomic force microscopy-like loading rates suggest a three-tier hierarchy of mechanical resilience: 9-mers resist the highest forces, 8-mers exhibit intermediate resistance, and 10-/11-mers rupture most easily. Our comprehensive analysis provides an atomistic framework for understanding the molecular mechanisms underlying the HLA-B∗51:01 pathobiology and offers quantitative parameters to guide the design of therapeutic peptides or small molecules to modulate antigen presentation in Behçet’s disease.
dc.description.harvestedfromManual
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuTÜBİTAK
dc.description.versionPublished Version
dc.identifier.WoSQuartileN/A
dc.identifier.doi10.1016/j.bpj.2026.04.028
dc.identifier.eissn1542-0086
dc.identifier.embargoN/A
dc.identifier.grantno119Z553
dc.identifier.issn0006-3495
dc.identifier.pubmed42036944
dc.identifier.urihttp://doi.org/10.1016/j.bpj.2026.04.028
dc.identifier.urihttps://hdl.handle.net/20.500.14288/33300
dc.keywordsPeptide
dc.keywordsMajor histocompatibility complex
dc.keywordsAntigen presentation
dc.keywordsAllele
dc.keywordsBiotinylation
dc.keywordsEpitope
dc.keywordsAntigen
dc.keywordsLimiting
dc.languageeng
dc.publisherCell Press
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofBiophysical Journal
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectMedicine
dc.titleMapping the peptide interaction fingerprint of the Behçet's disease-associated HLA-B(∗)51
dc.typeJournal Article
dspace.entity.typePublication
relation.isOrgUnitOfPublicationc747a256-6e0c-4969-b1bf-3b9f2f674289
relation.isOrgUnitOfPublication.latestForDiscoveryc747a256-6e0c-4969-b1bf-3b9f2f674289
relation.isParentOrgUnitOfPublication8e756b23-2d4a-4ce8-b1b3-62c794a8c164
relation.isParentOrgUnitOfPublication.latestForDiscovery8e756b23-2d4a-4ce8-b1b3-62c794a8c164

Files